Design and implementation of a high yield production system for recombinant expression of peptides

Microbial Cell Factories

Volumn 13, Issue 1, 2014, Pages

  Rodríguez, Vida ^a   Asenjo, Juan A ^a   Andrews, Barbara A ^a  

^a Dpt of Chemical Engineering   (Chile)

Author keywords

Cell penetrating peptides; Escherichia coli; Peptide therapeutics; Recombinant peptide production; Thrombin cleavage

Indexed keywords

CELL PENETRATING PEPTIDE; ESCHERICHIA COLI PROTEIN; HEXAHISTIDINE; HYBRID PROTEIN; PNC27 PROTEIN; PROTEIN; PROTEIN P53; RECOMBINANT PROTEIN; STEROID DELTA ISOMERASE; THROMBIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE EXPRESSION SYSTEM; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

ESCHERICHIA COLI;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CELL-PENETRATING PEPTIDES; CLONING, MOLECULAR; ESCHERICHIA COLI; INDUSTRIAL MICROBIOLOGY; MOLECULAR SEQUENCE DATA; PEPTIDES; PLASMIDS; RECOMBINANT FUSION PROTEINS; STEROID ISOMERASES; THROMBIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84900540654     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-13-65     Document Type: Article

References (42)

1. Vlieghe P, Lisowski V, Khrestchatisky M, Martinez J. Synthetic therapeutic peptides: science and market. Drug Discov Today 2010, 15:40-56. 10.1016/j.drudis.2009.10.009, 19879957.
2. Guzman F, Barberis S, Illanes A. Peptide synthesis: chemical or enzymatic. Electronic Journal of Biotechnology, vol. 10 2007, Valparaiso: Pontificia Universidad Católica de Valparaíso.
3. Andersson L, Blomberg L, Flegel M, Lepsa L, Nilsson B, Verlander M. Large-scale synthesis of peptides. Pept Sci 2000, 55:227-250.
4. Li Y. Recombinant production of antimicrobial peptides in Escherichia coli: a review. Protein Expr Purif 2011, 80:260-267. 10.1016/j.pep.2011.08.001, 21843642.
5. Lee EJ, Kim HS, Lee EY. Recombinant biocatalytic and cell-free synthesis of HIV fusion inhibitor. J Ind Eng Chem 2005, 11:515-521.
6. Rajendran L, Knölker HJ, Simons K. Subcellular targeting strategies for drug design and delivery. Nat Rev Drug Discov 2010, 9:29-42. 10.1038/nrd2897, 20043027.
7. Kaspar AA, Reichert JM. Future directions for peptide therapeutics development. Drug Discov Today 2013, 18:807-817. 10.1016/j.drudis.2013.05.011, 23726889.
8. Minko T, Dharap SS, Fabbricatore AT. Enhancing the efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular defense. Cancer Detect Prev 2003, 27:193-202. 10.1016/S0361-090X(03)00067-9, 12787726.
9. Kashiwagi H, McDunn JE, Goedegebuure PS, Gaffney MC, Chang K, Trinkaus K, Piwnica-Worms D, Hotchkiss RS, Hawkins WG. TAT-Bim induces extensive apoptosis in cancer cells. Ann Surg Oncol 2007, 14:1763-1771. 10.1245/s10434-006-9298-z, 17206479.
10. Michod D, Yang JY, Chen J, Bonny C, Widmann C. A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells. Oncogene 2004, 23:8971-8978. 10.1038/sj.onc.1207999, 15467750.
11. Jalota-Badhwar A, Kaul-Ghanekar R, Mogare D, Boppana R, Paknikar KM, Chattopadhyay S. SMAR1-Derived P44 peptide retains its tumor suppressor function through modulation of p53. J Biol Chem 2007, 282:9902-9913. 10.1074/jbc.M608434200, 17229733.
12. Hosotani R, Miyamoto Y, Fujimoto K, Doi R, Otaka A, Fujii N, Imamura M. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice. Clin Cancer Res 2002, 8:1271-1276.
13. Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T, Tsuruo T. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated smac peptide. Cancer Res 2003, 63:831-837.
14. Lv GS, Huo GC, Fu XY. Expression of milk-derived antihypertensive peptide in Escherichia coli. J Dairy Sci 2003, 86:1927-1931. 10.3168/jds.S0022-0302(03)73779-5, 12836926.
15. Li Y, Li X, Wang G. Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Protein Expr Purif 2006, 47:498-505. 10.1016/j.pep.2005.10.022, 16325420.
16. Rao X, Hu J, Li S, Jin X, Zhang C, Cong Y, Hu X, Tan Y, Huang J, Chen Z, Zhu J, Hu F. Design and expression of peptide antibiotic hPAB-beta as tandem multimers in Escherichia coli. Peptides 2005, 26:721-729. 10.1016/j.peptides.2004.12.016, 15808901.
17. Kuliopulos A, Walsh CT. Production, purification, and cleavage of tandem repeats of recombinant peptides. J Am Chem Soc 1994, 116:4599-4607.
18. Rodríguez JC, Wong L, Jennings PA. The solvent in CNBr cleavage reactions determines the fragmentation efficiency of ketosteroid isomerase fusion proteins used in the production of recombinant peptides. Protein Expr Purif 2003, 28:224-231. 10.1016/S1046-5928(02)00700-3, 12699685.
19. Li Q, Chen AS, Gayen S, Kang C. Expression and purification of the p75 neurotrophin receptor transmembrane domain using a ketosteroid isomerase tag. Microb Cell Fact 2012, 11:45. 10.1186/1475-2859-11-45, 3447675, 22510322.
20. Britton ZT, Hanle EI, Robinson AS. An expression and purification system for the biosynthesis of adenosine receptor peptides for biophysical and structural characterization. Protein Expr Purif 2012, 84:224-235. 10.1016/j.pep.2012.06.005, 3572917, 22722102.
21. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994, 269:10444-10450.
22. Brugidou J, Legrand C, Mery J, Rabie A. The retro-inverso form of a homeobox-derived short peptide is rapidly internalised by cultured neurones: a new basis for an efficient intracellular delivery system. Biochem Biophys Res Commun 1995, 214:685-693. 10.1006/bbrc.1995.2340, 7677782.
23. Selivanova G, Iotsova V, Okan I, Fritsche M, Strom M, Groner B, Grafstrom RC, Wiman KG. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat Med 1997, 3:632-638. 10.1038/nm0697-632, 9176489.
24. Kim AL, Raffo AJ, Brandt-Rauf PW, Pincus MR, Monaco R, Abarzua P, Fine RL. Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells. J Biol Chem 1999, 274:34924-34931. 10.1074/jbc.274.49.34924, 10574967.
25. Li Y, Mao Y, Rosal RV, Dinnen RD, Williams AC, Brandt-Rauf PW, Fine RL. Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells. Int J Cancer 2005, 115:55-64. 10.1002/ijc.20838, 15645452.
26. Dinnen RD, Drew L, Petrylak DP, Mao Y, Cassai N, Szmulewicz J, Brandt-Rauf P, Fine RL. Activation of targeted necrosis by a p53 peptide: a novel death pathway that circumvents apoptotic resistance. J Biol Chem 2007, 282:26675-26686. 10.1074/jbc.M701864200, 17636258.
27. Senatus PB, Li Y, Mandigo C, Nichols G, Moise G, Mao Y, Brown MD, Anderson RC, Parsa AT, Brandt-Rauf PW. Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide. Mol Cancer Ther 2006, 5:20-28.
28. Kanovsky M, Raffo A, Drew L, Rosal R, Do T, Friedman FK, Rubinstein P, Visser J, Robinson R, Brandt-Rauf PW, Michl J, Fine RL, Pincus MR. Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells. Proc Natl Acad Sci U S A 2001, 98:12438-12443. 10.1073/pnas.211280698, 60072, 11606716.
29. Do TN, Rosal RV, Drew L, Raffo AJ, Michl J, Pincus MR, Friedman FK, Petrylak DP, Cassai N, Szmulewicz J, Sidhu G, Fine RL, Brandt-Rauf PW. Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site. Oncogene 2003, 22:1431-1444. 10.1038/sj.onc.1206258, 12629507.
30. Sookraj KA, Adler V, Yazdi ES, Zenilman ME, Michl J, Pincus MR, Bowne WB. Novel p53-derived peptide induces necrosis by membrane-pore formation in pancreatic cancer cells. J Am Coll Surg 2008, 207:S97-S98.
31. Kelley AS, Victor A, Ehsan S-Y, Martin B, Michael EZ, Josef M, Matthew RP, Wilbur BB. W1961 Novel p53-derived peptide induces extensive necrosis in cancer cells. Gastroenterology 2008, 134:A-743.
32. Brandt-Rauf PW, Rosal RV, Fine RL, Pincus MR. Computational protein chemistry of p53 and p53 peptides. Front Biosci 2004, 9:2778-2787. 10.2741/1435, 15353313.
33. Rosal R, Pincus MR, Brandt-Rauf PW, Fine RL, Michl J, Wang H. NMR solution structure of a peptide from the mdm-2 binding domain of the p53 protein that is selectively cytotoxic to cancer cells. Biochemistry 2004, 43:1854-1861. 10.1021/bi035718g, 14967026.
34. Sookraj KA, Bowne WB, Adler V, Sarafraz-Yazdi E, Michl J, Pincus MR. The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide. Cancer Chemother Pharmacol 2010, 66:325-331. 10.1007/s00280-009-1166-7, 20182728.
35. Sarafraz-Yazdi E, Bowne WB, Adler V, Sookraj KA, Wu V, Shteyler V, Patel H, Oxbury W, Brandt-Rauf P, Zenilman ME, Michl J, Pincus MR. Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes. Proc Natl Acad Sci U S A 2010, 107:1918-1923. 10.1073/pnas.0909364107, 2836618, 20080680.
36. Yang JY, Zong CS, Xia W, Wei Y, Ali-Seyed M, Li Z, Broglio K, Berry DA, Hung MC. MDM2 Promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol 2006, 26:7269-7282. 10.1128/MCB.00172-06, 1592879, 16980628.
37. Bollag DM, Rozycki MD, Edelstein SJ. Protein methods 1996, New York: Wiley-Liss, Inc, Second.
38. Chang JY. Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate. Eur J Biochem 1985, 151:217-224. 10.1111/j.1432-1033.1985.tb09091.x, 2863141.
39. Cipáková I, Gasperík J, Hostinová E. Expression and purification of human antimicrobial peptide, dermcidin, in Escherichia coli. Protein Expr Purif 2006, 45:269-274. 10.1016/j.pep.2005.07.002, 16125410.
40. Sharpe S, Yau WM, Tycko R. Expression and purification of a recombinant peptide from the Alzheimer's beta-amyloid protein for solid-state NMR. Protein Expr Purif 2005, 42:200-210. 10.1016/j.pep.2005.03.005, 15939307.
41. Yin X, Wei D, Yi L, Tao X, Ma Y. Expression and purification of exendin-4, a GLP-1 receptor agonist, in Escherichia coli. Protein Expr Purif 2005, 41:259-265. 10.1016/j.pep.2004.10.014, 15866711.
42. Lee SY, Chang HN. Characteristics of poly(3-hydroxybutyric acid) synthesis by recombinant Escherichia coli. Ann N Y Acad Sci 1996, 782:133-142. 10.1111/j.1749-6632.1996.tb40555.x, 8659890.